DK1812002T3 - Behandling af mastitis - Google Patents

Behandling af mastitis

Info

Publication number
DK1812002T3
DK1812002T3 DK05800007.6T DK05800007T DK1812002T3 DK 1812002 T3 DK1812002 T3 DK 1812002T3 DK 05800007 T DK05800007 T DK 05800007T DK 1812002 T3 DK1812002 T3 DK 1812002T3
Authority
DK
Denmark
Prior art keywords
mastitis
treatment
Prior art date
Application number
DK05800007.6T
Other languages
English (en)
Inventor
Franz Pirro
Kristine Fraatz
Robrecht Froyman
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35462240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1812002(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Application granted granted Critical
Publication of DK1812002T3 publication Critical patent/DK1812002T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK05800007.6T 2004-11-12 2005-10-28 Behandling af mastitis DK1812002T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004054873A DE102004054873A1 (de) 2004-11-12 2004-11-12 Behandlung von Mastitis
PCT/EP2005/011553 WO2006050826A2 (de) 2004-11-12 2005-10-28 Behandlung von mastitis mit enrofloxacin

Publications (1)

Publication Number Publication Date
DK1812002T3 true DK1812002T3 (da) 2012-02-06

Family

ID=35462240

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05800007.6T DK1812002T3 (da) 2004-11-12 2005-10-28 Behandling af mastitis

Country Status (27)

Country Link
US (2) US20070265275A1 (da)
EP (1) EP1812002B1 (da)
JP (2) JP2008519781A (da)
KR (1) KR20070084182A (da)
CN (1) CN101056638A (da)
AR (1) AR051763A1 (da)
AT (1) ATE526970T1 (da)
BR (1) BRPI0517473A (da)
CA (1) CA2587187A1 (da)
CR (1) CR9109A (da)
DE (2) DE102004054873A1 (da)
DK (1) DK1812002T3 (da)
ES (1) ES2373449T3 (da)
HR (1) HRP20120002T1 (da)
IL (1) IL182993A (da)
MX (1) MX2007005526A (da)
NO (1) NO20072890L (da)
NZ (1) NZ555062A (da)
PE (1) PE20061139A1 (da)
PL (1) PL1812002T3 (da)
PT (1) PT1812002E (da)
RU (1) RU2413514C2 (da)
SI (1) SI1812002T1 (da)
SV (1) SV2006002296A (da)
UA (1) UA92593C2 (da)
WO (1) WO2006050826A2 (da)
ZA (1) ZA200703695B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5217276B2 (ja) * 2007-07-19 2013-06-19 ニプロ株式会社 注射用抗菌剤の製造方法
GB2480276A (en) * 2010-05-11 2011-11-16 Michael Hilary Burke Process for the preparation of an aqueous injectable enrofloxacin antimicrobial formulation
CN101933927A (zh) * 2010-06-30 2011-01-05 洛阳惠中兽药有限公司 一种含恩诺沙星六水合物组合物及其在制备治疗或预防家畜疾病的药物中的应用
NZ702087A (en) * 2012-06-29 2016-12-23 Bayer Animal Health Gmbh Pharmaceutical compositions and treatment of mastitis
EP2968231B1 (en) * 2013-03-15 2020-07-01 Boehringer Ingelheim Animal Health USA Inc. Antimicrobial polyamide compositions and mastitis treatment
RU2655772C1 (ru) * 2016-12-26 2018-05-29 Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" Йодсодержащий состав для лечения мастита у коров
RU2652354C1 (ru) * 2017-11-07 2018-04-25 федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный аграрный университет" (ФГБОУ ВО Волгоградский ГАУ) Способ терапии коров, больных маститом
CN108051512A (zh) * 2017-11-27 2018-05-18 佛山科学技术学院 一种牛乳中氟喹诺酮类药物残留量的检测方法
CN110812326B (zh) * 2019-11-04 2022-04-22 黑龙江省农业科学院畜牧兽医分院 一种辛伐他汀混悬乳剂及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3517709A1 (de) 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
CA2176298C (en) * 1995-06-27 2009-01-27 Dennis D. Copeland A single high dose fluoroquinolone treatment

Also Published As

Publication number Publication date
IL182993A (en) 2013-03-24
ES2373449T3 (es) 2012-02-03
WO2006050826A3 (de) 2006-07-27
UA92593C2 (ru) 2010-11-25
PE20061139A1 (es) 2006-12-29
AR051763A1 (es) 2007-02-07
ZA200703695B (en) 2008-08-27
PL1812002T3 (pl) 2012-03-30
SI1812002T1 (sl) 2012-03-30
NO20072890L (no) 2007-06-06
EP1812002B1 (de) 2011-10-05
BRPI0517473A (pt) 2008-10-07
CN101056638A (zh) 2007-10-17
JP2008519781A (ja) 2008-06-12
JP2013063985A (ja) 2013-04-11
CA2587187A1 (en) 2006-05-18
WO2006050826A2 (de) 2006-05-18
HRP20120002T1 (hr) 2012-02-29
PT1812002E (pt) 2011-12-30
KR20070084182A (ko) 2007-08-24
DE102004054873A1 (de) 2006-05-18
MX2007005526A (es) 2007-07-09
NZ555062A (en) 2009-12-24
IL182993A0 (en) 2007-09-20
RU2413514C2 (ru) 2011-03-10
US20130023540A1 (en) 2013-01-24
US20070265275A1 (en) 2007-11-15
DE202005022066U1 (de) 2012-12-06
EP1812002A2 (de) 2007-08-01
SV2006002296A (es) 2006-06-26
ATE526970T1 (de) 2011-10-15
RU2007121516A (ru) 2008-12-20
CR9109A (es) 2007-10-04

Similar Documents

Publication Publication Date Title
DK1720866T3 (da) Fremgangsmåde
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
CY2200156T2 (el) Επεξεργασια λυματων
DK1755661T3 (da) Gelsolin til anvendelse til behandling af infektioner
DE602005012267D1 (de) N von geräten
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DK1776136T3 (da) Behandling af tilstande, der involverer demyelinisering
DE602005026825D1 (de) Endoskop
DK1856975T3 (da) Behandling af havebrugsafgrøder
DE602005012636D1 (de) Erung
DK1732604T3 (da) Fremgangsmåder til behandling af hiv-infektion
DK1744781T3 (da) Behandling af infektionssygdomme
DK1962869T3 (da) Behandling af luftvejssygdomme
DK1630309T3 (da) Afløb
DK1812002T3 (da) Behandling af mastitis
DK1763520T3 (da) Anvendelse af trisubstituerede benzopyranoner
DE602005026124D1 (de) Endoskop
DK3332789T3 (da) Cladribinkur til behandling af multipel sklerose
DK1814555T3 (da) S-mirtazapin til behandling af hedeture
NO20043305D0 (no) Preparation of lodixanol
DE112005001784A5 (de) Geruchsverschluss
DE502004006772D1 (de) Wirkwerkzeug-Barre
DK1940447T3 (da) Behandling af neurodegenrative lidelser